UnitedHealth Group Incorporated $UNH Shares Newly Acquired by Verus Capital Partners LLC

Verus Capital Partners LLC acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) during the third quarter, HoldingsChannel reports. The fund acquired 1,629 shares of the healthcare conglomerate’s stock, valued at approximately $598,000.

Other large investors also recently bought and sold shares of the company. General Partner Inc. acquired a new stake in shares of UnitedHealth Group during the third quarter worth $512,000. PBCay One RSC Ltd acquired a new position in shares of UnitedHealth Group in the 1st quarter valued at $14,343,000. Lee Johnson Capital Management LLC purchased a new position in UnitedHealth Group in the 2nd quarter worth $6,180,000. Kinsale Capital Group Inc. raised its stake in UnitedHealth Group by 13.4% in the 2nd quarter. Kinsale Capital Group Inc. now owns 38,510 shares of the healthcare conglomerate’s stock worth $16,006,000 after acquiring an additional 4,557 shares during the last quarter. Finally, Kelleher Financial Advisors lifted its position in UnitedHealth Group by 135.9% during the 2nd quarter. Kelleher Financial Advisors now owns 5,495 shares of the healthcare conglomerate’s stock worth $2,284,000 after acquiring an additional 3,166 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

Analysts Set New Price Targets

A number of equities research analysts recently commented on UNH shares. Stephens set a $500.00 target price on UnitedHealth Group in a research report on Friday, October 16th. Oppenheimer raised their price target on shares of UnitedHealth Group from $420.00 to $500.00 and gave the stock an “outperform” rating in a research report on Friday, July 17th. Zacks Research cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 14th. Jefferies Financial Group upped their price objective on shares of UnitedHealth Group from $401.00 to $490.00 and gave the company a “buy” rating in a report on Friday, July 17th. Finally, TD Cowen reiterated a “hold” rating and issued a $402.00 price objective on shares of UnitedHealth Group in a research note on Thursday, October 15th. Twenty investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $463.93.

Read Our Latest Stock Analysis on UNH

Insider Activity

In related news, CEO Patrick Conway sold 1,169 shares of the business’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer directly owned 15,328 shares in the company, valued at $5,977,920. The trade was a 7.09% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.19% of the stock is currently owned by corporate insiders.

UnitedHealth Group Stock Down 0.0%

Shares of UNH opened at $394.14 on Monday. UnitedHealth Group Incorporated has a 52 week low of $255.96 and a 52 week high of $461.62. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $353.16 billion, a price-to-earnings ratio of 22.51, a PEG ratio of 1.43 and a beta of 0.51. The stock’s 50-day moving average price is $390.62 and its 200-day moving average price is $364.03.

UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, beating the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The company had revenue of $112.72 billion during the quarter, compared to analysts’ expectations of $111.31 billion. During the same period last year, the business earned $2.59 earnings per share. UnitedHealth Group’s quarterly revenue was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 20.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th will be paid a dividend of $2.32 per share. The ex-dividend date of this dividend is Monday, December 7th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.4%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 53.00%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid.

Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.

Founded in 1977 as United HealthCare Corporation, the company is headquartered in Minnetonka, Minnesota.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.